Dispensys AG has been acquired by Sulzer Mixpac AG
The owner of Dispensys AG has sold the company to Sulzer Mixpac AG. Financial details of this transaction have not been disclosed.
Dispensys develops and produces dispensers and cartridges for every 2-component application in the dental market such as for impression materials, temporary crown and bridge materials, cements, bleaching products and others. The owner of Dispensys wanted to focus on the development of new products.
Sulzer Mixpac is the world’s leading manufacturer and supplier of metering, mixing and dispensing systems and disposable mixers for reactive multicomponent materials.
Oaklins' team in Switzerland acted as the exclusive financial advisor to the seller.
Talk to the deal team
Related deals
Afric Phar has been acquired by Pharma Capital
Pharma Capital S.A. has acquired a significant stake in the Moroccan pharmaceutical group Afric Phar, which includes leading companies Afric Phar, Pharmis and Partner Lab, from the Chaoui family, in one of the largest transactions in the Moroccan pharmaceutical sector.
Learn moreXiel Limited has been acquired by MIS Healthcare
MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.
Learn moreBayer AG has entered into a takeover agreement with Cara Care
Bayer AG, renowned for its advancements in healthcare and life sciences, has finalized the acquisition of Cara Care (HiDoc Technologies GmbH), which entered debtor-in-possession proceedings in October 2024. Cara Care, an innovative digital health platform and official DiGA, aligns perfectly with Bayer’s strategic focus on digital health and the expansion of its innovative solutions portfolio. The transaction is expected to close in Spring 2025.
Learn more